Tradestie Institutional Equity Comparison Engine

CRESW vs CPHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CPHC Overall Edge

CPHC Captures Institutional Edge (3โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Canterbury Park Holding Corporation 'New' Common Stock (CPHC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, CRESW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CPHC at 20.1x Forward P/E and 5.5% operating margin (+4.2% YoY). In options structure, CRESW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CPHC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CPHC
CRESW N/M vs CPHC 20.1x Fwd P/E
Growth & Margin Winner CPHC
Op Margin N/A vs 5.5% ยท YoY N/A vs +4.2%
Momentum & Technical Winner CPHC
1Y -97.3% vs -5.2% ยท 52W Pos 2% vs 40%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CRESW NASDAQ
Cresud S.A.C.I.F. y A. Warrant
Institutional Equity
$0.03
+1953.33% 1D
Market Cap N/A
1M Return -97.59%
1Y Return -97.3%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 55.0
CPHC NASDAQ
Canterbury Park Holding Corporation 'New' Common Stock
Services-Racing, Including Track Operation
$15.60
-0.83% 1D
Market Cap $81.8M
1M Return -2.07%
1Y Return -5.17%
Forward P/E 20.1x
Unified AI Score
55.6 / 100 HOLD
Tech 49.0 Fund 54.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRESW -97.3% CPHC -5.17% Spread: +90.92 pp (CPHC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CRESW TTM Op. Margin: N/A CPHC TTM Op. Margin: 5.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRESW vs CPHC. Trailing 12-month operating profitability (CRESW N/A vs CPHC 5.5%) and valuation multiples (CRESW N/M vs CPHC 20.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRESW (0) vs CPHC (10)
Institutional Metric CRESW CPHC Criterion Row Winner
Market Capitalization Scale N/A $81.8M Larger Scale CPHC
Trailing P/E Ratio Valuation N/M 131.1x Lower Multiple CPHC
Forward P/E Ratio Valuation N/M 20.1x Lower Multiple CPHC
Revenue Growth (YoY) Growth N/A +4.2% Higher Growth CPHC
Operating Margin (TTM) Profitability N/A 5.5% Higher Margin CPHC
Net Profit Margin Profitability N/A 1.0% Higher Margin CPHC
Return on Equity (ROE) Capital Efficiency N/A 0.7% Higher ROE CPHC
52-Week Range Position Momentum 2% ($0โ€“$2) 40% ($15โ€“$17) Stronger Trend CPHC
Beta / 30D Volatility Risk Regime 23.08ฮฒ ยท 7022% Vol 0.03ฮฒ ยท 18% Vol Lower Realized Risk CPHC
Unified Institutional Score Composite Signal 43.5 / 100 (HOLD) 55.6 / 100 (HOLD) Higher Composite CPHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRESW vs CPHC Buy Guide
CRESW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CRESW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CPHC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CPHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRESW nor CPHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.